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Abstract: 
Kawasaki disease is an acute febrile multisystem vasculitic syndrome of unknown etiology, occurring mostly 
in infants and children younger than 5 years of age. 
We present a 13-month-old male with Kawasaki disease from whom was found Human Bocavirus DNA in 
nasopharyngeal secretions. 
Human Bocavirus DNA in a patient with Kawasaki disease raised question about the coincidental or possible 
etiological association. 
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Introduction:  
The cause of Kawasaki disease (KD) is unclear and there is no specific method of diagnosis, clinical 
suspicion is based on the identification of defined clinical criteria [1]. KD is a multisystemic vasculitis of 
small to medium size vessels [1, 2]. The natural history of KD reveals that coronary artery aneurysms occur 
as a sequel of the vasculitis in 20% to 25% of untreated children. Although the cause of KD remains 
unknown, clinical trials have established effective therapies, despite the absence of a proven cause. 
Intravenous immunoglobulin (IVIG) plus aspirin lowers the rate of coronary artery aneurysms from 20% to 
between 3% and 5% [3]. 
Immunopathological mechanisms involved in the pathogenesis of KD are unclear. Although its etiology 
remains unknown, the clinical and epidemiological features of this disease suggest that it is infectious [1, 4]. 
Epstein–Barr virus, adenovirus and cytomegalovirus have all been considered as possible agents that are 
involved in KD [5, 6]. The recently discovered Human Bocavirus (HBoV) is the first member of the family 
Parvoviridae, genus Bocavirus, to be potentially associated with human disease [7]. Several studies have 
identified HBoV in respiratory specimens from children with acute respiratory disease but the full spectrum 
of clinical disease and the epidemiology of HBoV infection remain unclear [8-10]. A study using 
nasopharyngeal aspirates from children hospitalized with fever also revealed HBoV nucleic acid in 5 patients 
hospitalized with KD [2]. 
 
Case report:  
A 13 months male child, previous healthy, with updated vaccination including anti-meningococcal and anti-
pneumococcal vaccine was admitted to our hospital on October 2006, after five days of fever because a 
suspicion of Kawasaki disease. 
On day 1 he had fever with rash (on trunk and limbs) and presents leukocytosis, neutrophilia and elevated C-
reactive protein (4.0 mg/dL). A progressive worsening of the general state was verified and on day 4 he was 
treated with ampicilin (80 mg/kg/day, 6/6h). On day 5 he maintained fever, irritability and developed mouth 
enanthem, glossitis, rash with perioral desquamation, swelling of the hands and feets, conjunctivitis and 
jaundice. On clinical exam he had tachycardia, systolic murmur and hepatomegaly. Laboratory evaluation at 
admission in our hospital, on day 5, showed 15860/ml leukocyte count with 15.3 % neutrophils, hemoglobin 
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10.3 g/dl, platelet count 225000/ml, C-reactive protein 13.7 mg/dL and elevation of transaminase (63/86 
UI/L). Renal function, cultures (blood, urine and feces) and serology for adenovirus, cytomegalovirus, 
epstein-Barr virus and parvovirus B19 were within normal limits or negatives. 
Chest x-ray revealed a bibasal non-specific interstitial infiltrate. Echocardiography (day 2) show a slight 
mitral valve insufficiency and normal coronary arteries and on day 6 it identified left 
coronary aneurysm, which confirmed the diagnosis of KD. Detection of adenovirus, influenza virus A and B, 
parainfluenza virus 1-3 and respiratory syncytial virus in nasopharyngeal secretions by an 
immunofluorescence were negative. Human Bocavirus was identified in nasopharyngeal secretions by real 
time polymerase chain reaction (PCR) followed by sequencing of PCR product. 
Treatment with gammaglobulin (2g/Kg) in a single dose and high dose of diary anti-platelet aggregate led to 
rapid resolution without relapse, progressive normalization of the liver function and transitional 
thrombocytosis. Cardiac outcome was excellent with resolution of coronary aneurysm. 
 
Discussion: 
During the past 30 years, identifying of a definitive infectious agent that causes KD has not been possible. 
Certain intracellular pathogens and superantigens from bacteria have been implicated in its 
immunopathogenesis. Several lines of evidence support the fact that KD is an infectious disease, such as 
acute onset of a self-limited illness, presence of fever, increased susceptibility in younger age groups and 
geographic clustering of outbreaks with a seasonal predominance (later winter and early spring). Various 
bacteria such as Streptococcus pyogenes, Staphylococcus aureus, Mycoplasma pneumoniae and 
Chlamydophila pneumoniae have been sporadically isolated from patients with KD. Suspected viral agents, 
especially lymphotrophic viruses such as Adenovirus, Epstein-Barr virus, Parvovirus B19, Herpesvirus 6, 
Parainfluenza type 3 virus, Human immunodeficiency virus, Measles, Rotavirus, Dengue virus and 
Varicella-zoster virus have been implicated as potential causes of KD, but no proof has emerged to 
incriminate one agent [11]. 
This new parvovirus, genus Bocavirus (HBoV) has been identified in nasopharyngeal secretions from 
children with acute febrile respiratory infection. The potential of causing other non respiratory diseases has 
been under discussion [12, 13]. Later publications reported the virus in the gastro-intestinal tract and serum, 
referring to a systemic dissemination [14, 15]. 
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The detection of Human Bocavirus DNA in a patient with Kawasaki disease raised question about the 
coincidental or possible etiological association. Based on the clinical, epidemiological, and 
immunological features of KD, the pathogenesis of KD could be a hyperimmune reaction in 
genetically susceptible children to a ubiquitous virus. Gendrel and colleagues [2] have also identified 
HBoV by PCR in five (31.2%) patients with KD, suggesting that this emerging virus may also play a 
pathogenic role in some cases of Kawasaki disease. Additional studies are required to understand the 
physiopathology of this new virus. 
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